Amdocs Ltd. (DOX) Misses Q4 EPS by 1c, to Buy Celcite Management for $129M
Amdocs Ltd. (NYSE: DOX) reported Q4 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
